Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct 20:12:983878.
doi: 10.3389/fonc.2022.983878. eCollection 2022.

Tumor microenvironment and exosomes in brain metastasis: Molecular mechanisms and clinical application

Affiliations
Review

Tumor microenvironment and exosomes in brain metastasis: Molecular mechanisms and clinical application

Yirizhati Aili et al. Front Oncol. .

Abstract

Metastasis is one of the important biological features of malignant tumors and one of the main factors responsible for poor prognosis. Although the widespread application of newer clinical technologies and their continuous development have significantly improved survival in patients with brain metastases, there is no uniform standard of care. More effective therapeutic measures are therefore needed to improve prognosis. Understanding the mechanisms of tumor cell colonization, growth, and invasion in the central nervous system is of particular importance for the prevention and treatment of brain metastases. This process can be plausibly explained by the "seed and soil" hypothesis, which essentially states that tumor cells can interact with various components of the central nervous system microenvironment to produce adaptive changes; it is this interaction that determines the development of brain metastases. As a novel form of intercellular communication, exosomes play a key role in the brain metastasis microenvironment and carry various bioactive molecules that regulate receptor cell activity. In this paper, we review the roles and prospects of brain metastatic tumor cells, the brain metastatic tumor microenvironment, and exosomes in the development and clinical management of brain metastases.

Keywords: brain tumor; exosomes; metastases; tumor cell; tumor microenvironment.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Sources and formation processes of brain metastases. (A) The most common sources of brain metastases are lung cancer (40%-50%), followed by breast cancer (15%-20%), skin cancer (mainly melanoma) accounting for 5%-10%, and gastrointestinal malignancy (4%-6%). (B) Tumor cells and secreted vesicle contents can disrupt the integrity of BBB, thereby promoting tumor metastasis to intracranial, interacting with surrounding astrocytes, microglia/macrophages, and then influencing the biological behavior of brain metastasis through various pathways such as secreting cytokine networks, direct contact and exosomes, and establishing complex networks. (C) Tumor cells can produce mutual adaptive changes with the components of the central nervous system microenvironment, and it is this interaction that determines the occurrence and development of brain metastatic lesions. (D) Metastatic foci appear in the skull, producing obvious mass and edematic effects, which seriously affects the quality of life of patients.
Figure 2
Figure 2
The role of exosomes in brain metastases. The first mechanism of primary tumor exosomes is that they can promote their own progression and metastasis. The second general mechanism is that exosomes derived from primary tumor cells promote the proliferation of brain metastases, regulated immune mechanism to promote tumor cell proliferation, and regulate the stability of tumor cells, and can be useful diagnostic and/or prognostic biomarkers.

References

    1. Steeg PS, Camphausen KA, Smith QR. Brain metastases as preventive and therapeutic targets. Nat Rev Cancer. (2011) 11(5):352–63. doi: 10.1038/nrc3053 - DOI - PMC - PubMed
    1. Lowery FJ, Yu D. Brain metastasis: Unique challenges and open opportunities. Biochim Biophys Acta Rev Cancer. (2017) 1867(1):49–57. doi: 10.1016/j.bbcan.2016.12.001 - DOI - PMC - PubMed
    1. Valiente M, Ahluwalia MS, Boire A, Brastianos PK, Goldberg SB, Lee EQ, et al. . The evolving landscape of brain metastasis. Trends Cancer. (2018) 4(3):176–96. doi: 10.1016/j.trecan.2018.01.003 - DOI - PMC - PubMed
    1. Eichler AF, Chung E, Kodack DP, Loeffler JS, Fukumura D, Jain RK, et al. . The biology of brain metastases-translation to new therapies. Nat Rev Clin Oncol (2011) 8(6):344–56. doi: 10.1038/nrclinonc.2011.58 - DOI - PMC - PubMed
    1. Lee HH, Chen CH, Chuang HY, Huang YW, Huang MY. Brain surgery in combination with tyrosine kinase inhibitor and whole brain radiotherapy for epidermal growth factor receptor-mutant non-small-cell lung cancer with brain metastases. Sci Rep (2019) 9(1):16834. doi: 10.1038/s41598-019-53456-z - DOI - PMC - PubMed